VISTAGEN THERAPEUTICS, INC. Gains (Losses) on Recourse Debt
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Gains (Losses) on Recourse Debt of $2.37 million for the 9-month period ending 2014-12-31, per its 10-Q filed 2015-02-17.
Discontinued › Income Statement › Other Income
us-gaap:GainsLossesOnRecourseDebt · last filed 2015-02-17
- VISTAGEN THERAPEUTICS, INC. gains (losses) on recourse debt for the quarter ending 2014-12-31 was $0.00.
| Period end | Gains (Losses) on Recourse Debt 3 month | Gains (Losses) on Recourse Debt 6 month | Gains (Losses) on Recourse Debt 9 month |
|---|---|---|---|
| 2014-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-17 | $2.37M 10-Q · filed 2015-02-17 | |
| 2014-09-30 | $2.37M 10-Q · filed 2014-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |